China Shineway Pharmaceutical Group Limited (C1S) — Financial Flexibility Index
China Shineway Pharmaceutical Group Limited (C1S) has a Financial Flexibility Index of 0.08x as of June 2023. Free cash flow of €185.26 Million (operating CF €160.69 Million minus capex €24.57 Million) represents 0% of total liabilities (€2.26 Billion). Check China Shineway Pharmaceutical Group Limi total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China Shineway Pharmaceutical Group Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see China Shineway Pharmaceutical Group Limi (C1S) cash conversion ratio.
Annual Financial Flexibility Index for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year free cash flow to debt coverage for China Shineway Pharmaceutical Group Limited. Explore debt repayment capacity of China Shineway Pharmaceutical Group Limi to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €1.37 Billion | €1.17 Billion | €2.72 Billion | ▲ +17.7% |
| 2024 | 0.43x | €1.10 Billion | €963.13 Million | €2.57 Billion | ▲ +1.0% |
| 2023 | 0.42x | €1.08 Billion | €932.63 Million | €2.54 Billion | ▼ -36.7% |
| 2022 | 0.67x | €1.24 Billion | €1.11 Billion | €1.85 Billion | ▲ +9.5% |
| 2021 | 0.61x | €796.78 Million | €703.15 Million | €1.30 Billion | ▲ +23.2% |
| 2020 | 0.50x | €704.59 Million | €638.57 Million | €1.42 Billion | ▲ +47.3% |
| 2019 | 0.34x | €456.40 Million | €368.00 Million | €1.35 Billion | ▼ -50.7% |
| 2018 | 0.68x | €659.92 Million | €532.59 Million | €966.01 Million | ▼ -1.0% |
| 2017 | 0.69x | €582.47 Million | €490.65 Million | €844.16 Million | ▼ -31.1% |
| 2016 | 1.00x | €840.32 Million | €733.53 Million | €838.59 Million | ▲ +0.9% |
| 2015 | 0.99x | €851.26 Million | €744.71 Million | €857.13 Million | ▲ +14.8% |
| 2014 | 0.86x | €877.34 Million | €773.16 Million | €1.01 Billion | ▲ +44.8% |
| 2013 | 0.60x | €781.77 Million | €519.89 Million | €1.31 Billion | — |